Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SDK1 antisense RNA 1 (SDK1-AS1)
- Target
- SDK1-AS1
- Molecular classification
- Long non-coding RNA (lncRNA), Natural antisense transcript, Non-coding RNA
01
Overview
SDK1 antisense RNA 1 (SDK1-AS1) is a long non-coding RNA molecule transcribed from the SDK1 locus, on the opposite (antisense) DNA strand relative to the SDK1 protein-coding gene. As an antisense RNA, it is likely to regulate SDK1 expression through hybridization and post-transcriptional or epigenetic mechanisms, including RNA interference, transcriptional interference, or modulation of chromatin structure. Although the general class of antisense lncRNAs is linked to fundamental biological processes such as X-chromosome inactivation, genomic imprinting, and disease development, there is currently no direct evidence that SDK1-AS1 itself serves as a therapeutic target, biomarker, or drug-interacting molecule in humans.
- Other names
- SDK1-AS1AC073316.3
02
Mechanism of action
Not applicable; no known drugs directly target SDK1-AS1
03
Biological functions
Regulation of gene expression through RNA–RNA interactionsLikely involved in epigenetic and transcript-level modulation of SDK1 expressionMay participate in transcription interference and RNA interference mechanisms (via formation of complementary double-stranded structures with SDK1 mRNA)
04
Disease associations
None currently specific or established for SDK1-AS1; more generally, antisense lncRNAs are implicated in cancer, genomic imprinting, and other regulatory/inflammatory conditions
Beyond the preview
Go deeper on SDK1 antisense RNA 1 (SDK1-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SDK1 antisense RNA 1 (SDK1-AS1).